BBA
AXDX icon

Baader Bank Aktiengesellschaft’s Accelerate Diagnostics AXDX Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,750
Closed -$20.5K – 422
2023
Q1 		$20.5K Buy
+3,750
New +$22.5K ﹤0.01% 344

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baader Bank Aktiengesellschaft's AXDX Position: Q2 2023 in Review

Baader Bank Aktiengesellschaft sold out of Accelerate Diagnostics (AXDX) in Q2 2023, closing a stake of 3,750 shares — an estimated $20.5K sold.

Baader Bank Aktiengesellschaft first reported a position in AXDX in Q1 2023 and held it in 1 quarter. The position peaked at $20.5K in Q1 2023. 51 funds tracked by Wall St. Rank hold AXDX as of Q2 2023.

  • Baader Bank Aktiengesellschaft reported no remaining Accelerate Diagnostics position as of Q2 2023 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 3,750 Accelerate Diagnostics shares in Q2 2023, an estimated $20.5K.
  • Baader Bank Aktiengesellschaft first reported a position in Accelerate Diagnostics in Q1 2023 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Accelerate Diagnostics position peaked at $20.5K in Q1 2023.
  • 51 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2023.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2023, filed 11 Aug 2023.